Abdera raises funds to advance radiopharmaceuticals to treat cancer
Pharmaceutical Technology
APRIL 20, 2023
Biopharmaceutical company Abdera Therapeutics has raised $142m in combined Series A and B financing to engineer and advance antibody-based radiopharmaceuticals to treat cancer. The Series A financing round was led by Amplitude Ventures and Versant Ventures, with Northview Ventures, AbCellera and adMare BioInnovations as participants.
Let's personalize your content